Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine

Recruiting N/A Interventional Study
Nutrition Type 2 Diabetes T2DM T2DM (Type 2 Diabetes Mellitus) Diabetes Education Diabetes Type 2 Diabetes Mellitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
University of North Carolina, Chapel Hill · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is designed to test the feasibility and preliminary efficacy of a continuous glucose monitor (CGM)-augmented food is medicine (FIM) intervention for adults with type 2 diabetes and nutrition or food insecurity. This study will learn if a FIM intervention ("intervention") that includes access to real-time CGM and nutrition counseling can increase engagement, improve glycemic management, …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Able to complete study activities in English * Aged ≥18 years * Type 2 diabetes as defined by self-report and confirmed by ICD-10 codes * Chart review will be conducted by the study team and a diagnosis of type 2 diabetes (E.11.xx) from either the problem list or a diagnosi…
Contacts

Penny Wang, MS

+1 (919) 843-7720

penny_wang@med.unc.edu

CONTACT

Angela Fruik, MPH, RD, LDN

919-962-6348

angela.fruik@unc.edu

CONTACT